EcoR1 Capital as of June 30, 2023
Portfolio Holdings for EcoR1 Capital
EcoR1 Capital holds 52 positions in its portfolio as reported in the June 2023 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Prothena Corp SHS (PRTA) | 19.4 | $791M | 12M | 68.28 | |
Apellis Pharmaceuticals (APLS) | 12.2 | $497M | 5.5M | 91.10 | |
Sarepta Therapeutics (SRPT) | 10.3 | $419M | 3.7M | 114.52 | |
Johnson & Johnson Call Option (JNJ) | 6.9 | $281M | 1.7M | 165.52 | |
Galapagos Nv Spon Adr (GLPG) | 5.7 | $234M | 5.8M | 40.66 | |
Morphic Hldg (MORF) | 5.4 | $221M | 3.8M | 57.33 | |
Revolution Medicines (RVMD) | 4.7 | $193M | 7.2M | 26.75 | |
Anaptysbio Inc Common (ANAB) | 3.7 | $153M | 7.5M | 20.34 | |
ACADIA Pharmaceuticals (ACAD) | 3.5 | $144M | 6.0M | 23.95 | |
Xencor (XNCR) | 3.2 | $132M | 5.3M | 24.97 | |
Zymeworks Del (ZYME) | 2.8 | $116M | 13M | 8.64 | |
Blueprint Medicines (BPMC) | 2.8 | $114M | 1.8M | 63.20 | |
Arvinas Ord (ARVN) | 2.4 | $100M | 4.0M | 24.82 | |
Springworks Therapeutics (SWTX) | 2.2 | $91M | 3.5M | 26.22 | |
Kura Oncology (KURA) | 1.6 | $67M | 6.3M | 10.58 | |
Relay Therapeutics (RLAY) | 1.3 | $52M | 4.2M | 12.56 | |
Jazz Pharmaceuticals Shs Usd (JAZZ) | 1.1 | $46M | 368k | 123.97 | |
Voyager Therapeutics (VYGR) | 1.1 | $44M | 3.9M | 11.45 | |
Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.9 | $35M | 5.6M | 6.19 | |
Edgewise Therapeutics (EWTX) | 0.7 | $27M | 3.5M | 7.75 | |
Oric Pharmaceuticals (ORIC) | 0.6 | $27M | 3.4M | 7.76 | |
Atea Pharmaceuticals (AVIR) | 0.6 | $26M | 7.0M | 3.74 | |
Nuvation Bio Com Cl A (NUVB) | 0.6 | $25M | 14M | 1.80 | |
Alector (ALEC) | 0.6 | $24M | 4.1M | 6.01 | |
Crinetics Pharmaceuticals In (CRNX) | 0.6 | $24M | 1.3M | 18.02 | |
Allogene Therapeutics (ALLO) | 0.5 | $22M | 4.5M | 4.97 | |
Graphite Bio | 0.5 | $22M | 8.5M | 2.60 | |
Ovid Therapeutics (OVID) | 0.5 | $20M | 6.1M | 3.28 | |
Ngm Biopharmaceuticals (NGM) | 0.4 | $17M | 6.4M | 2.59 | |
Tango Therapeutics (TNGX) | 0.3 | $13M | 4.0M | 3.32 | |
Tscan Therapeutics (TCRX) | 0.3 | $13M | 5.0M | 2.50 | |
Generation Bio (GBIO) | 0.3 | $11M | 2.0M | 5.50 | |
Third Harmonic Bio (THRD) | 0.2 | $10M | 2.1M | 4.81 | |
Phathom Pharmaceuticals (PHAT) | 0.2 | $10M | 700k | 14.32 | |
Dyne Therapeutics (DYN) | 0.2 | $9.0M | 799k | 11.25 | |
Prime Medicine (PRME) | 0.2 | $8.8M | 600k | 14.65 | |
Zentalis Pharmaceuticals (ZNTL) | 0.2 | $8.5M | 300k | 28.21 | |
Janux Therapeutics (JANX) | 0.1 | $5.4M | 453k | 11.87 | |
Prelude Therapeutics (PRLD) | 0.1 | $5.2M | 1.2M | 4.50 | |
Proqr Thrapeutics N V Shs Euro (PRQR) | 0.1 | $4.8M | 3.0M | 1.62 | |
Hookipa Pharma Inc equity (HOOK) | 0.1 | $4.0M | 4.6M | 0.88 | |
Aligos Therapeutics (ALGS) | 0.1 | $3.8M | 3.9M | 0.97 | |
Allakos (ALLK) | 0.1 | $3.3M | 749k | 4.36 | |
Aeglea Biotherapeutics | 0.1 | $2.3M | 5.0M | 0.45 | |
Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.0 | $1.7M | 963k | 1.80 | |
Tempest Therapeutics (TPST) | 0.0 | $1.4M | 1.1M | 1.27 | |
4d Molecular Therapeutics In (FDMT) | 0.0 | $1.2M | 67k | 18.07 | |
Poseida Therapeutics I (PSTX) | 0.0 | $1.2M | 676k | 1.76 | |
Newamsterdam Pharma Company *w Exp 11/22/202 (NAMSW) | 0.0 | $793k | 67k | 11.89 | |
Kronos Bio (KRON) | 0.0 | $562k | 327k | 1.72 | |
Caremax *w Exp 06/08/202 (CMAXW) | 0.0 | $311k | 100k | 3.11 | |
Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $37k | 67k | 0.55 |